U.S. Markets open in 4 hrs 21 mins

DarioHealth Corp. (DRIO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
19.02-1.60 (-7.76%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close20.62
Open20.39
Bid0.00 x 800
Ask0.00 x 800
Day's Range19.02 - 20.39
52 Week Range5.55 - 31.85
Volume222,984
Avg. Volume291,325
Market Cap292.821M
Beta (5Y Monthly)1.28
PE Ratio (TTM)N/A
EPS (TTM)-5.55
Earnings DateMar 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est29.04
  • DRIO: Fourth Quarter and Fiscal Year 2020 Financial and Operational Results
    Zacks Small Cap Research

    DRIO: Fourth Quarter and Fiscal Year 2020 Financial and Operational Results

    By John Vandermosten, CFA NASDAQ:DRIO READ THE FULL DRIO RESEARCH REPORT On March 9, 2021, DarioHealth Corp. (NASDAQ:DRIO) announced its fourth quarter and FY:20 operational and financial results and filed its form 10-K. 2020 marked a transformative year for Dario as it maneuvered towards a B2B2C-oriented strategy, winning three major accounts in the last several months, including two Fortune 500 companies and one of the largest integrated healthcare systems in New Mexico. Over the last year, Dario added to its management team, appointed new members to its Scientific Advisory Board and presented results from a study showing efficacy of Dario’s platform in glucose readings in diabetic adults over 65. Following the reporting period, Dario acquired Upright Technologies, an early-stage app-and-device based platform in the musculoskeletal (MSK) space. The new addition was consummated in a mostly stock deal and addresses posture and other MSK conditions, expanding Dario’s offerings in

  • DarioHealth Reports Fourth Quarter and Full Year 2020 Results and Operational Highlights
    PR Newswire

    DarioHealth Reports Fourth Quarter and Full Year 2020 Results and Operational Highlights

    DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the fourth quarter and full year 2020 and provided a corporate and commercial update.

  • ACCESSWIRE

    DarioHealth Corp. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / March 9, 2021 / DarioHealth Corp. (NASDAQ:DRIO) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 9, 2021 at 8:30 AM Eastern Time.